Zobrazeno 1 - 10
of 88
pro vyhledávání: '"R F, Barth"'
Publikováno v:
Journal of microscopy. 254(3)
Boron neutron capture therapy (BNCT) of cancer depends on the selective delivery of a sufficient number of boron-10 ((10)B) atoms to individual tumour cells. Cell killing results from the (10)B (n, α)(7) Li neutron capture and fission reactions that
Autor:
R. F. Barth
The overall goal of this project was to evaluate either boronated EGF or anti-EGFR monoclonal antibodies (MoAbs) as delivery agents for boron neutron capture therapy (BNCT).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0daf756a42ba3c4a34d32cec9abf4e54
https://doi.org/10.2172/825198
https://doi.org/10.2172/825198
Publikováno v:
Journal of neuro-oncology. 55(1)
We have previously reported a method for labeling epidermal growth factor (EGF) with technetium-99m and have shown that 99mTc-EGF localized in EGF receptor (R) positive intracerebral C6EGFR rat gliomas following intratumoral (i.t.) injection of the r
Publikováno v:
Cancer research. 61(22)
Boron neutron capture therapy (BNCT) is dependent on the selective accumulation of boron-10 in tumor cells relative to the contiguous normal cells. Ion microscopy was used to evaluate the microdistribution of boron-10 from p-boronophenylalanine (BPA)
Autor:
C R, Gibson, A E, Staubus, R F, Barth, W, Yang, N M, Kleinholz, R B, Jones, K, Green-Church, W, Tjarks, A H, Soloway
Publikováno v:
Drug metabolism and disposition: the biological fate of chemicals. 29(12)
Boron neutron capture therapy (BNCT) is based on a nuclear capture reaction that occurs when boron-10, a stable isotope, is irradiated with low energy neutrons to produce high-energy alpha particles and recoiling lithium-7 nuclei. The purpose of the
Autor:
W, Tjarks, R F, Barth, J H, Rotaru, D M, Adams, W, Yang, R G, Kultyshev, J, Forrester, B A, Barnum, A H, Soloway, S G, Shore
Publikováno v:
Anticancer research. 21(2A)
The in vivo uptake of dodecahydro-closo-dodecaborate derivatives substituted with phosphate- and bisphosphonate groups was evaluated in two different experimental tumor model systems and compared to other boronated and non-boronated compounds. These
Publikováno v:
Anticancer research. 20(5B)
A boronated derivative of dequalinium, a delocalized lipophilic cation (DLC), was synthesized as a potential boron carrier for the selective targeting of mitochondria in malignant versus benign cells for boron neutron capture therapy (BNCT), a binary
Autor:
W, Yang, R F, Barth, J H, Rotaru, C P, Boesel, D A, Wilkie, J C, Bresnahan, M, Hadjiconstantinou, V M, Goettl, D D, Joel, M M, Nawrocky
Publikováno v:
Journal of neuro-oncology. 48(3)
Sodium borocaptate (BSH) and boronophenylalanine (BPA) are two drugs that have been used clinically for boron neutron capture therapy (BNCT) of brain tumors. We previously have reported that hyperosmotic mannitol-induced disruption of the blood-brain
Autor:
Jianghai Wang, A. J. Lunato, Jin-Cong Zhuo, Staffan Eriksson, Werner Tjarks, R. F. Barth, J. Cai, A. H. Soloway, Dianne M. Adams, Weihua Ji
Publikováno v:
Contemporary Boron Chemistry ISBN: 9780854048359
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2d7d67a563b4a279a993ad44bcd9a884
https://doi.org/10.1039/9781847550644-00127
https://doi.org/10.1039/9781847550644-00127
Publikováno v:
American journal of clinical pathology. 113(5)
Transfusion-associated graft-vs-host disease (TA-GVHD) is a rare complication of transfusion. We report fatal TA-GVHD in a 63-year-old coronary artery bypass patient of European descent after an RBC transfusion from an unrelated donor. The patient ha